Severe combined immunodeficiencies and related disorders - PubMed (original) (raw)
Review
Severe combined immunodeficiencies and related disorders
Alain Fischer et al. Nat Rev Dis Primers. 2015.
Abstract
Severe combined immunodeficiencies (SCIDs) comprise a group of rare, monogenic diseases that are characterized by an early onset and a profound block in the development of T lymphocytes. Given that adaptive immunity is abrogated, patients with SCID are prone to recurrent infections caused by both non-opportunistic and opportunistic pathogens, leading to early death unless immunity can be restored. Several molecular defects causing SCIDs have been identified, along with many other defects causing profound, albeit incomplete, T cell immunodeficiencies; the latter are referred to as atypical SCIDs or combined immunodeficiencies. The pathophysiology of many of these conditions has now been characterized. Early, accurate and precise diagnosis combined with the ongoing implementation of newborn screening have enabled major advances in the care of infants with SCID, including better outcomes of allogeneic haematopoietic stem cell transplantation. Gene therapy is also becoming an effective option. Further advances and a progressive extension of the indications for gene therapy can be expected in the future. The assessment of long-term outcomes of patients with SCID is now a major challenge, with a view to evaluating the quality and sustainability of immune restoration, the risks of sequelae and the ability to relieve the non-haematopoietic syndromic manifestations that accompany some of these conditions.
Similar articles
- Modern management of primary T-cell immunodeficiencies.
Pachlopnik Schmid J, Güngör T, Seger R. Pachlopnik Schmid J, et al. Pediatr Allergy Immunol. 2014 Jun;25(4):300-13. doi: 10.1111/pai.12179. Epub 2014 Jan 3. Pediatr Allergy Immunol. 2014. PMID: 24383740 Review. - Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
Fischer A, Le Deist F, Hacein-Bey-Abina S, André-Schmutz I, Basile Gde S, de Villartay JP, Cavazzana-Calvo M. Fischer A, et al. Immunol Rev. 2005 Feb;203:98-109. doi: 10.1111/j.0105-2896.2005.00223.x. Immunol Rev. 2005. PMID: 15661024 Review. - Gene therapy for primary adaptive immune deficiencies.
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Fischer A, et al. J Allergy Clin Immunol. 2011 Jun;127(6):1356-9. doi: 10.1016/j.jaci.2011.04.030. J Allergy Clin Immunol. 2011. PMID: 21624615 Review. - Evolving Gene Therapy in Primary Immunodeficiency.
Thrasher AJ, Williams DA. Thrasher AJ, et al. Mol Ther. 2017 May 3;25(5):1132-1141. doi: 10.1016/j.ymthe.2017.03.018. Epub 2017 Mar 31. Mol Ther. 2017. PMID: 28366768 Free PMC article. Review. - Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
Sponzilli I, Notarangelo LD. Sponzilli I, et al. Acta Biomed. 2011 Apr;82(1):5-13. Acta Biomed. 2011. PMID: 22069950 Review.
Cited by
- Genetically-determined defects of T cell development.
Notarangelo LD. Notarangelo LD. Allergy Asthma Proc. 2024 Sep 1;45(5):326-331. doi: 10.2500/aap.2024.45.240028. Allergy Asthma Proc. 2024. PMID: 39294907 Free PMC article. Review. - Restoration of T and B Cell Differentiation after RAG1 Gene Transfer in Human RAG1 Defective Hematopoietic Stem Cells.
Sorel N, Díaz-Pascual F, Bessot B, Sadek H, Mollet C, Chouteau M, Zahn M, Gil-Farina I, Tajer P, van Eggermond M, Berghuis D, Lankester AC, André I, Gabriel R, Cavazzana M, Pike-Overzet K, Staal FJT, Lagresle-Peyrou C. Sorel N, et al. Biomedicines. 2024 Jul 5;12(7):1495. doi: 10.3390/biomedicines12071495. Biomedicines. 2024. PMID: 39062069 Free PMC article. - The rise and fall of adenine clusters in the gas phase: a glimpse into crystal growth and nucleation.
Oluwatoba DS, Safoah HA, Do TD. Oluwatoba DS, et al. Anal Bioanal Chem. 2024 Sep;416(23):5037-5048. doi: 10.1007/s00216-024-05442-2. Epub 2024 Jul 20. Anal Bioanal Chem. 2024. PMID: 39031229 - Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia.
Howley E, Soomann M, Kreins AY. Howley E, et al. J Clin Immunol. 2024 Mar 8;44(3):79. doi: 10.1007/s10875-024-01678-w. J Clin Immunol. 2024. PMID: 38457046 Free PMC article. - Combined Immunodeficiency Caused by a Novel Nonsense Mutation in LCK.
Keller B, Kfir-Erenfeld S, Matusewicz P, Hartl F, Lev A, Lee YN, Simon AJ, Stauber T, Elpeleg O, Somech R, Stepensky P, Minguet S, Schraven B, Warnatz K. Keller B, et al. J Clin Immunol. 2023 Dec 19;44(1):4. doi: 10.1007/s10875-023-01614-4. J Clin Immunol. 2023. PMID: 38112969 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources